[HTML][HTML] Association of COVID-19 vaccination and clinical severity of patients infected with Delta or Omicron variants—China, May 21, 2021–February 28, 2022

M Li, Q Liu, D Wu, L Tang, X Wang, T Yan, Z An… - China CDC …, 2022 - ncbi.nlm.nih.gov
Compared with the international mRNA and adenovirus-vectored coronavirus disease 2019
(COVID-19) vaccines, there is less real-world research data about breakthrough cases in …

[HTML][HTML] Protective effect of inactivated COVID-19 vaccines against progression of SARS-CoV-2 Omicron and delta variant infections to pneumonia in Beijing, China, in …

J Li, R Song, Z Yuan, Z Xu, L Suo, Q Wang, Y Li, Y Gao… - Vaccines, 2022 - mdpi.com
This real-world study explores the effect of coronavirus disease 2019 (COVID-19)
inactivated vaccines on the prevention of asymptomatic or mild Delta or Omicron variant …

[HTML][HTML] A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines

X He, J Su, Y Ma, W Zhang, S Tang - Frontiers in Immunology, 2022 - frontiersin.org
It is urgently needed to update the comprehensive analysis about the efficacy or
effectiveness of COVID-19 vaccines especially during the COVID-19 pandemic caused by …

[HTML][HTML] Effectiveness of inactivated COVID-19 vaccines against COVID-19 caused by the SARS-CoV-2 Delta and Omicron Variants: a retrospective cohort study

Q Hua, D Zheng, B Yu, X Tan, Q Chen, L Wang… - Vaccines, 2022 - mdpi.com
Background: Real-world evidence on the effectiveness of inactivated vaccines against the
Delta and Omicron (BA. 2.38) variants remains scarce. Methods: A retrospective cohort study …

[HTML][HTML] Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death

Z Huang, S Xu, J Liu, L Wu, J Qiu, N Wang, J Ren, Z Li… - BMC medicine, 2022 - Springer
Background Limited data are available on the effectiveness of inactivated and Ad5-nCoV
COVID-19 vaccines in real-world use—especially against Omicron variants in SARS-CoV-2 …

[HTML][HTML] Estimation of real-world vaccination effectiveness of mRNA COVID-19 vaccines against Delta and Omicron variants in Japan

S Kodera, EA Rashed, A Hirata - Vaccines, 2022 - mdpi.com
A resurgence of COVID-19-positive cases has been observed in many countries in the latter
half of 2021. The primary reasons for this resurgence are the waning immunity of vaccination …

Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant …

H Xu, H Li, H You, P Zhang, N Li, N Jiang… - Emerging microbes & …, 2023 - Taylor & Francis
It is critical to determine the real-world performance of vaccines against coronavirus disease
2019 (COVID-19) so that appropriate treatments and policies can be implemented. There …

Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study

L Tang, Y Zhang, F Wang, D Wu, ZH Qian, R Zhang… - BMJ open, 2022 - bmjopen.bmj.com
Objective Two COVID-19 outbreaks occurred in Henan province in early 2022—one was a
Delta variant outbreak and the other was an Omicron variant outbreak. COVID-19 vaccines …

[HTML][HTML] Effectiveness of inactivated COVID-19 vaccines against delta-variant COVID-19: evidence from an outbreak in inner Mongolia autonomous region, China

C Ma, C Huang, W Wang, Y Song, X Jiang, X Tian… - Vaccines, 2023 - mdpi.com
Phase 3 clinical trials and real-world effectiveness studies showed that China's two main
inactivated COVID-19 vaccines are very effective against serious illness. In November 2021 …

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

P Sritipsukho, T Khawcharoenporn… - Emerging Microbes & …, 2023 - Taylor & Francis
The surge in coronavirus disease 2019 (COVID-19) caused by the Omicron variants of the
severe acute respiratory syndrome coronavirus 2 necessitates researches to inform vaccine …